Back to results
US 2026/0265198 A1Published application
Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethylpyridine-3-carboxylate
AssigneeImbria Pharmaceuticals, Inc.
InventorsNeil Buckley, Dan Belmont, Sarah Bethune, Krista Diaz
Life of this patent
Estimating the term…
Abstract
The invention provides polymorphs of a compound of Formula (X): The invention also provided pharmaceutical compositions containing polymorphs of the compound and methods treating conditions in a subject by providing polymorphs of the compound.
Claims17
-20. (canceled)
A composition comprising a compound of Formula (X):
- wherein the compound comprises at least 95% by weight of a Form A polymorph.
Dependencies are inferred from the claim text.